How Has The Computer Vision in Continuous Glucose Monitoring Devices Market Size Evolved In Recent Years?
The continuous glucose monitoring devices market has seen considerable growth due to a variety of factors.
• There has been a swift expansion in the market size of continuous glucose monitoring devices in the recent past. The market is expected to expand from $8.41 billion in 2024 to $9.86 billion in 2025, marking a compound annual growth rate (CAGR) of 17.22%.
Several factors contribute to this historic period growth including enhanced patient safety and improved health outcomes, a rise in the demand for diabetes management devices, increased usage of CGM devices, a surge in the diabetic patient count, and heightened trust from patients.
What Does Future Hold for The Continuous Glucose Monitoring Devices Market Size?
The continuous glucose monitoring devices market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of continuous glucose monitoring devices is projected to experience a swift expansion in the upcoming years. The expected growth rate is a compound annual growth rate (CAGR) of 16.96%, thereby hitting $18.45 billion in 2029. Factors contributing to this growth during the forecast period include a surge in healthcare expenditure, heightened awareness, a rise in the number of diabetes instances, an escalated prevalence of diabetes, and the increasing popularity of continuous glucose monitoring devices. Major trends that will be observed in the forecasted period include technological breakthroughs, advancements in CGM technology, commonplace of mergers and acquisitions, regulatory consents, along with partnerships and collaborations.
Which Key Drivers Are Propelling Th Continuous Glucose Monitoring Devices Market's Growth?
Rising diabetes incidence is predicted to fuel the continuous glucose monitoring devices market's expansion in the future. Diabetes, a disorder where the body can't properly manage blood sugar due to a lack of sufficient insulin or insulin resistance, is predominantly caused by factors such as poor diets, sedentary lifestyles, obesity, older demographics, and genetic susceptibility. Continuous Glucose Monitoring (CGM) devices are an effective tool in diabetes management, offering real-time blood glucose level data that facilitate quick adjustments to treatment tactics and lifestyle habits. For example, in March 2024, the Office for Health Improvement & Disparities, a UK government agency, reported that the percentage of type 1 diabetes patients receiving all eight suggested care processes rose by 22% between March 2022 and 2023, and the percentage for type 2 diabetes went up by 21%. The percentage reaching the target HbA1c levels escalated to 37.9%, the highest figure ever recorded by the National Diabetes Audit (NDA). Consequently, the growing incidence of diabetes is spurring the advancement of the continuous glucose monitoring devices market.
What Is The Segmentation Of The Global Continuous Glucose Monitoring Devices Market?
The continuous glucose monitoring devices market covered in this report is segmented –
1) By Component: Transmitters, Sensors, Receivers
2) By Connectivity: Bluetooth, 4G
3) By Demography: Child Population, Adult Population
4) By Application: Gestational Diabetes, Type-2 Diabetes, Type-1 Diabetes
5) By End-Use: Hospitals, Homecare Settings, Other End Users
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters, Integrated Transmitter-Receiver Systems
2) By Sensors: Enzyme-Based Sensors, Electrochemical Sensors, Non-Invasive Sensors
3) By Receivers: Mobile Device Integration (Smartphone Receivers), Standalone Receivers, Cloud-Based Data Sync Receivers
Pre-Book The Continuous Glucose Monitoring Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Continuous Glucose Monitoring Devices Market Landscape?
Major firms in the continuous glucose monitoring devices market are focused on creating advanced technologies, like readily available continuous glucose monitors. Such advancements aim to improve accessibility, precision, and user-friendliness for those controlling their blood sugar levels. These over-the-counter continuous glucose monitors empower individuals to manage their blood sugar levels uninterrupted without the need for a prescription. For example, in September 2024, known medical device company based in the US, Abbott Laboratories, rolled out a Lingo continuous glucose monitoring (CGM) system. This system offers the users up-to-the-minute glucose information. This monitoring is constant and immediate, enabling users to keep track of their blood sugar all day. The device is fashionable, easy to use, with clear displays, and works smoothly with mobile apps for tracking trends or getting alerts.
Who Are the Key Players in the Continuous Glucose Monitoring Devices Market?
Major companies operating in the continuous glucose monitoring devices market are include:
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Sanofi S.A.
• Abbott Laboratories
• Medtronic Public Limited Company
• Novo Nordisk A/S
• Becton Dickinson and Company
• A. Menarini Diagnostics S.r.l.
• Dexcom Inc.
• Bionime Corporation
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG
• Tandem Diabetes Care Inc.
• i-Sens Inc.
• Senseonics Holdings Inc.
• Medtrum Technologies Inc.
• Biolinq Inc.
• GlySens Incorporated
• Glucotrack Inc.
• Nemaura Medical Inc.
What are the Regional Insights into the Continuous Glucose Monitoring Devices Market?
North America was the largest region in the continuous glucose monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
